Cultivation of hemp, or non-psychoactive cannabis, of no more than 1% THC, is legal in Uruguay and is subject to a licence from the Ministry of Public Health. The whole plant, including the flowers, can be processed for the extraction of CBD; however, a licence is in the realm of the Institute of Regulation and Control of Cannabis. This report provides a thorough analysis of the current regulatory regime for CBD and cannabis in Uruguay. It covers extracts, finished products, import/export laws and regulations surrounding both medical and recreational cannabis.
Sign up to our platform and you will have access to our latest business and regulatory news analysis, which keeps you updated with the latest hot topics in the sector.
Do the Novel Food regulations in Europe affect your business?
CBD as a Novel Food: the future for edibles in Europe
This new CBD-Intel report examines key aspects and drivers of the edibles market itself before looking in detail at the Novel Food regulations, both at EU level and in non-EU markets: notably the UK, as well as Switzerland and Norway.
Questions it considers and answers include whether CBD really is novel, whether approvals are likely to be generic or applicant-specific, how the Novel Food Catalogue and RASFF operate, and the costs of Novel Food applications.
This report also includes a 1-hour consultation call with CBD-Intel’s analyst team.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
Table of contents
